Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial)
- 2 October 1990
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (11) , D40-D45
- https://doi.org/10.1016/0002-9149(90)90475-g
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Second generation calcium channel blockers in the treatment of chronic heart failure: Are they any better than their predecessors?*Journal of the American College of Cardiology, 1989
- Prognostic importance of atrial natriuretic peptide in patients with chronic heart failureJournal of the American College of Cardiology, 1989
- The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria.Circulation, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- A sensitive radioimmunoassay of atrial natriuretic peptide in human plasma, using a tracer with an immobilized glycouril agentClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.Heart, 1987
- Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart FailureNew England Journal of Medicine, 1986
- Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.Circulation, 1986
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.Circulation, 1984